|
Staats, H F; Ennis Jr, F A (1999) IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens. J Immunol 162:6141-7
|
|
Porgador, A; Staats, H F; Faiola, B et al. (1997) Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo. J Immunol 158:834-41
|
|
Staats, H F; Montgomery, S P; Palker, T J (1997) Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses. AIDS Res Hum Retroviruses 13:945-52
|
|
Staats, H F; Nichols, W G; Palker, T J (1996) Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J Immunol 157:462-72
|
|
Liao, H X; Haynes, B F (1995) Role of adhesion molecules in the pathogenesis of rheumatoid arthritis. Rheum Dis Clin North Am 21:715-40
|
|
Haynes, B F; Moody, M A; Heinley, C S et al. (1995) HIV type 1 V3 region primer-induced antibody suppression is overcome by administration of C4-V3 peptides as a polyvalent immunogen. AIDS Res Hum Retroviruses 11:211-21
|
